Literature DB >> 2373688

Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cells in vitro.

N S Fedarko1, J D Termine, M F Young, P G Robey.   

Abstract

Osteoblasts elaborate a dynamic extracellular matrix that is constructed and mineralized as bone is formed. This matrix is primarily composed of collagen, along with noncollagenous proteins which include glycoproteins and proteoglycans. After various times in culture, human bone cells were labeled with [35S]sulfate, [3H] leucine/proline, or [3H]glucosamine and the metabolism of hyaluronan and four distinct species of proteoglycans (PGs) was assayed in the medium, cell layer, and intracellular pools. These cells produce hyaluronan (Mr approximately 1,400,000; a chondroitin sulfate PG (CSPG), Mr approximately 600,000; a heparan sulfate PG (HSPG), Mr approximately 400,000; and two dermatan sulfate PGs with Mr approximately 270,000 (biglycan, PG I) and Mr approximately 135,000 (decorin, PG II) that distribute between the medium and cell layer. Two days following subculture, 12 h [35S]sulfate steady-state labeling yielded a composition of 24, 27, 31, and 18% for total CSPG, HSPG, biglycan, and decorin, respectively. While HSPG and decorin levels and distribution between medium and cell layer remained relatively constant during steady-state labeling at different times in culture, CSPG and biglycan levels increased dramatically at late stages of growth, and their distribution changed throughout culture. These results were independent of cell density, media depletion, and labeling pool effects. In contrast, hyaluronan synthesis was uncoupled from PG synthesis and apparently density-dependent. Pulse chase labeling at different stages of culture showed that the CSPG and decorin behaved as secretory PGs. Both HSPG and biglycan underwent catabolism, with HSPG possessing a t1/2 of 8 h and biglycan a t1/2 of 4 h. While the rate of HSPG turnover did not appreciably change between early and late culture, that of biglycan decreased. The mRNA for decorin was constant, while that of biglycan changed during culture. These results suggest that each PG possesses a distinct pattern of cellular and temporal distribution that may reflect specific stages in matrix formation and maturation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373688

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Expression of RPS4X in fibroblasts from patients with structural aberrations of the X chromosome.

Authors:  W Just; C Geerkens; K R Held; W Vogel
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

2.  Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.

Authors:  Gerald J Atkins; Peter S Rowe; Hui P Lim; Katie J Welldon; Renee Ormsby; Asiri R Wijenayaka; Lesya Zelenchuk; Andreas Evdokiou; David M Findlay
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

3.  Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells.

Authors:  P Y D'avis; C R Frazier; J R Shapiro; N S Fedarko
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

4.  Plasma-membrane-intercalated heparan sulphate proteoglycans in an osteogenic cell line (UMR 106-01 BSP).

Authors:  D J McQuillan; R J Midura; V C Hascall; M Yanagishita
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae.

Authors:  H Nakamura; S Kenmotsu; H Sakai; H Ozawa
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

6.  Catalytic and substrate promiscuity: distinct multiple chemistries catalysed by the phosphatase domain of receptor protein tyrosine phosphatase.

Authors:  Bharath Srinivasan; Hanna Marks; Sreyoshi Mitra; David M Smalley; Jeffrey Skolnick
Journal:  Biochem J       Date:  2016-05-17       Impact factor: 3.857

7.  Characterization of collagen II fibrils containing biglycan and their effect as a coating on osteoblast adhesion and proliferation.

Authors:  Timothy Douglas; Sascha Heinemann; Ute Hempel; Carolin Mietrach; Christiane Knieb; Susanne Bierbaum; Dieter Scharnweber; Hartmut Worch
Journal:  J Mater Sci Mater Med       Date:  2007-09-13       Impact factor: 3.896

8.  The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene.

Authors:  C Geerkens; U Vetter; W Just; N S Fedarko; L W Fisher; M F Young; J D Termine; P G Robey; D Wöhrle; W Vogel
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

9.  Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of beta-glycerophosphate and ascorbic acid.

Authors:  D D Dean; Z Schwartz; L Bonewald; O E Muniz; S Morales; R Gomez; B P Brooks; M Qiao; D S Howell; B D Boyan
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

Review 10.  Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid.

Authors:  Tommaso Iannitti; Daniele Lodi; Beniamino Palmieri
Journal:  Drugs R D       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.